The European Foundation for the Study of Diabetes (EFSD) and Sanofi have established a joint program to promote new projects that advance the understanding of autoimmunity in type 1 diabetes. This program aims to stimulate and accelerate European research to improve the understanding of any aspect of autoimmunity in type 1 diabetes, its pathogenesis, screening and monitoring, clinical course, and interventions. Grants are offered for both basic and clinical studies.

The EFSD-Sanofi European Diabetes Research Programme on autoimmunity in type 1 diabetes is intended to stimulate and accelerate European research aimed at improving understanding of any aspect of autoimmunity in type 1 diabetes, its pathogenesis, screening and monitoring, its clinical course and its interventions. Grants are offered for basic and clinical studies.

Mechanism of Support and Review

Research will be supported through the award of grants, each of up to Euro 100,000 for basic and/or clinical projects. The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application. EFSD may, on advisement from the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.

All projects need to provide comprehensive justification of their budget and a clear description of both, the requested amount from EFSD as well as the available funding for the project from other sources, if applicable (see Review Considerations).

• Applications must come from non-profit institutions or groups of such institutions in Europe and associated countries.
• The principal investigator and any co-investigators must be employed at a non-profit institution, and the study must be conducted at their workplace in Europe or an associated country.
• Applications must be submitted through the EFSD program portal.

In case of interest, please click on "m'interessa" and we will contact you.